Sponsored by Ultragenyx Pharmaceutical Inc.
| Variant ID | 16 |
|---|---|
| Genomic Coordinate (GRCh38) | g.22033006A>G |
| Variant | c.1A>G |
| Variant Start Position | 1 |
| Location | Exon 1 |
| Amino Acid Change | p.Met1? |
| ACMG Call | - |
| ACMG Call Last Revised Date | 4/28/2021 |
| Predicted ACMG Call | Uncertain Significance | Effect Type | Missense |
| Variant Type | SNV |
| PMID | 21994957, 30682568, 34806794 |
| Article Count | 3 |
| Times Observed | < 3 |
| Clinical Phenotype | - |
| ACMG Categories | pm2, ppc |
| ACMG Explanations | pm2: chrX:22051124 ref:A alt:G was not found in gnomAD exomes or genomes. |
| Variant in Clinvar | No |
| ClinVar Classification | - |
| Categories In Literature | ppc |
| No Contrary Evidence Found | Yes |
| ExAC Allele Frequency | - |
| Thousand Genomes Allel Frequency | - |
| Ontology Relations | - |
| hg19 Mapping Failed | No |
| Literature Alleles | - |
| GnomAD Alleles | - |
| DBNSFP Alleles | X-22051124-A-G |
| Other Alleles | X-22051124-ATG-GTT X-22051124-ATG-GTC X-22051124-ATG-GTA |
| Note | nan |
| Warnings | - |